Search research articles
Contact Us
Filters
Showing results (131-140 of 224) with videos related to
Page
of 23
Sort By:
Biomedical Optics Express
|
April 21, 2018
Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography
Robert A Byers, Raman Maiti, Simon G Danby, et al.
The British Journal of Dermatology
|
July 12, 2008
The autoimmune regulator gene (AIRE) is strongly associated with vitiligo
R Tazi-Ahnini, A J G McDonagh, D A Wengraf, et al.
The British Journal of Dermatology
|
July 18, 2023
Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial
Stephan Weidinger, Thomas Bieber, Michael J Cork, et al.
Letters in Applied Microbiology
|
February 7, 2013
Evaluation of a method to detect Mycobacterium bovis in air samples from infected Eurasian badgers (Meles meles) and their setts
R M Jones, R Ashford, J Cork, et al.
Allergy and Asthma Proceedings
|
September 3, 2021
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities
Jonathan M Spergel, Michael S Blaiss, Peter Lio, et al.
Heredity
|
November 13, 2001
Association analysis of IL1A and IL1B variants in alopecia areata
R Tazi-Ahnini, A J McDonagh, A Cox, et al.
Tissue Antigens
|
January 16, 2008
Genetic analysis of autoimmune regulator haplotypes in alopecia areata
D A Wengraf, A J G McDonagh, T R J Lovewell, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 22, 2023
Targeting Skin Barrier Function in Atopic Dermatitis
Ellen H van den Bogaard, Peter M Elias, Elena Goleva, et al.
Dermatology and Therapy
|
July 2, 2024
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda J Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Journal of the American Academy of Dermatology
|
September 30, 2024
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study
Amy S Paller, Jonathan I Silverberg, Eric L Simpson, et al.
Page
of 23
Search research articles
Search
Showing results (131-140 of 224) with videos related to
Sort By:
Page
of 23
Biomedical Optics Express
|
April 21, 2018
Sub-clinical assessment of atopic dermatitis severity using angiographic optical coherence tomography
Robert A Byers, Raman Maiti, Simon G Danby, et al.
The British Journal of Dermatology
|
July 12, 2008
The autoimmune regulator gene (AIRE) is strongly associated with vitiligo
R Tazi-Ahnini, A J G McDonagh, D A Wengraf, et al.
The British Journal of Dermatology
|
July 18, 2023
Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial
Stephan Weidinger, Thomas Bieber, Michael J Cork, et al.
Letters in Applied Microbiology
|
February 7, 2013
Evaluation of a method to detect Mycobacterium bovis in air samples from infected Eurasian badgers (Meles meles) and their setts
R M Jones, R Ashford, J Cork, et al.
Allergy and Asthma Proceedings
|
September 3, 2021
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities
Jonathan M Spergel, Michael S Blaiss, Peter Lio, et al.
Heredity
|
November 13, 2001
Association analysis of IL1A and IL1B variants in alopecia areata
R Tazi-Ahnini, A J McDonagh, A Cox, et al.
Tissue Antigens
|
January 16, 2008
Genetic analysis of autoimmune regulator haplotypes in alopecia areata
D A Wengraf, A J G McDonagh, T R J Lovewell, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 22, 2023
Targeting Skin Barrier Function in Atopic Dermatitis
Ellen H van den Bogaard, Peter M Elias, Elena Goleva, et al.
Dermatology and Therapy
|
July 2, 2024
Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations
Melinda J Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, et al.
Journal of the American Academy of Dermatology
|
September 30, 2024
The effect of dupilumab on caregiver- and patient-reported outcomes in young children with moderate-to-severe atopic dermatitis: Results from a placebo-controlled, phase 3 study
Amy S Paller, Jonathan I Silverberg, Eric L Simpson, et al.
Page
of 23